Sign in
4/A

Changes in Ownership

CLOVER HEALTH INVESTMENTS, CORP. /DE Filed Acc 0001801170-25-000170

CEO, Counterpart Health sold 15,203 shares at $3.26 ($49,562)

  • CEO, Counterpart Health acquired 379,866 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wai Conrad CEO, Counterpart Health 2024-09-13 Grant or award 10b5-1 +379,866 1,699,767 D: show line 1 in the form
Wai Conrad CEO, Counterpart Health 2025-07-08 Sale 10b5-1 −15,203 $3.26 $49,562 1,613,498 I: show line 2 in the form
Open-market sales · 15,203 sh · avg $3.26 · $49,562
Loading xslF345X05/wk-form4a_1752189870.xml…